ArticlePigment cell & melanoma research2026
Heme Oxygenase-1 Differentially Controls Pigmentation in Physiological and Pathological Melanogenesis.
Article in Pigment cell & melanoma research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Melanogenesis is a defining feature of melanocyte biology and influences melanoma pathogenesis; however, tumor-specific regulators of this process remain incompletely understood. Here, we investigate how heme oxygenase-1 (HO-1) regulates pigmentation in malignant and homeostatic contexts. Using B16-F10 melanoma cells engineered to express varying levels of HO-1, we show that HO-1 abundance correlates with pigmentation intensity and tyrosinase activity, without affecting transcription of core melanogenesis genes. Under pigment-inducing conditions, HO-1 inversely regulates intracellular melanin retention and pigment export, with inhibition of melanosome transfer confirming a role for HO-1 in melanosome trafficking and secretion. Co-culture experiments reveal that stromal HO-1 promotes melanoma pigmentation through paracrine effects on tyrosinase expression. Transcriptomic analyses of human melanoma datasets show that HMOX1 expression correlates with pathways related to melanosome acidification, copper homeostasis, and lysosomal transport rather than classical melanogenic programs. In contrast, HO-1 is dispensable in the non-malignant melanocytic conditions tested here-murine iPSC-derived melanocytes during differentiation and Melan-A melanocytes. Together, these findings identify HO-1 as a context-dependent regulator of melanoma pigmentation and a potential selective target for modulating pigmentation-dependent tumor traits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.